Stock TXG 10X GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases 10x Genomics, Inc.

Equities

TXG

US88025U1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
27.59 USD +2.57% Intraday chart for 10x Genomics, Inc. -1.25% -50.70%
Apr. 18 Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating MT
Mar. 26 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Petition Denied For Lacking Section 112(f) Construction And Fintiv
AQ
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?
AQ
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision
AQ
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
PR
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision
AQ
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
PR
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
PR
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform
AQ
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
PR
Element Biosciences Announces Senior Vice President of Global Sales and Support
AQ
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
PR
10x Genomics: Q4 Earnings Snapshot
AQ
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
PR
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
PR
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
PR
TXG Alert: Johnson Fistel Announces Investigation of 10x Genomics for Potential Securities Law Violations
BU
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
PR
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
PR
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
10x Genomics Launches Xenium Catalyst Network
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXG Stock
  4. News 10x Genomics, Inc.
  5. Press Releases